UBS Group AG - PROMETHEUS BIOSCIENCES INC ownership

PROMETHEUS BIOSCIENCES INC's ticker is RXDX and the CUSIP is 74349U108. A total of 119 filers reported holding PROMETHEUS BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 10.24 and the average weighting 1.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of PROMETHEUS BIOSCIENCES INC
ValueSharesWeighting
Q1 2023$777,426
-79.1%
7,244
-78.6%
0.00%
-100.0%
Q4 2022$3,723,940
+3224.9%
33,854
+1679.0%
0.00%
Q3 2022$112,000
+646.7%
1,903
+249.8%
0.00%
Q2 2022$15,000
-98.9%
544
-98.5%
0.00%
Q1 2022$1,374,000
+218.8%
36,393
+233.6%
0.00%
Q4 2021$431,000
+1952.4%
10,909
+1149.6%
0.00%
Q3 2021$21,000
+50.0%
873
+12.5%
0.00%
Q1 2021$14,0007760.00%
Other shareholders
PROMETHEUS BIOSCIENCES INC shareholders Q2 2022
NameSharesValueWeighting ↓
72 Investment Holdings, LLC 1,848,024$198,329,93693.93%
CHI Advisors LLC 934,135$100,251,36726.61%
Cormorant Asset Management, LP 1,655,000$177,61511.70%
Boxer Capital, LLC 1,897,500$203,64010.00%
RTW INVESTMENTS, LP 3,272,104$351,162,2017.31%
Decheng Capital Management III (Cayman), LLC 150,000$16,098,0006.50%
Waypoint Capital Advisors, LLC 154,466$16,577,2925.40%
Affinity Asset Advisors, LLC 150,000$16,098,0005.31%
Perceptive Advisors 1,272,694$136,585,5204.03%
Ikarian Capital, LLC 125,926$13,514,3783.07%
View complete list of PROMETHEUS BIOSCIENCES INC shareholders